Precise Therapy for Patients With AML: Experts Discuss Clinical Challenges and Future Directions

In this online CME-certified program, faculty experts explore the latest developments in individualizing therapy for patients with AML through the use of recently approved targeted agents, novel immunotherapies, and investigational agents. 
Farhad Ravandi, MD
Program Director
person default
Ellen K. Ritchie, MD
Eytan M. Stein, MD

Downloadable Slidesets

In this downloadable slideset, Farhad Ravandi, MD, provides expert insights on key clinical biomarkers for prognostication and individualizing treatment for patients with AML.

Farhad Ravandi, MD
Program Director
Released: May 31, 2019

In this downloadable slideset, Farhad Ravandi, MD, reviews current and investigational uses of immunotherapy for patients with AML.

Farhad Ravandi, MD
Program Director
Released: May 31, 2019

In this downloadable slideset, Eytan M. Stein, MD, provides expert insights and guidance on individualizing treatment for patients with AML with FLT3 or IDH1/2 mutations.

Eytan M. Stein, MD Released: May 31, 2019

In this downloadable slideset, Ellen K. Ritchie, MD, spotlights targeted therapies and other agents in clinical development for patients with AML.

person default Ellen K. Ritchie, MD Released: May 31, 2019

In this downloadable slideset, Ellen K. Ritchie, MD, provides expert insights and guidance on individualizing treatment for patients with newly diagnosed AML.

person default Ellen K. Ritchie, MD Released: May 31, 2019

On-Demand Webcast

Watch this on-demand Webcast from the CCO AML satellite at ASCO 2019, featuring expert discussion on key clinical biomarkers; new antibody-based therapies; treatment strategies for newly diagnosed AML and AML positive for IDH or FLT3 mutations; and emerging molecular targets.

Farhad Ravandi, MD
Program Director
person default Ellen K. Ritchie, MD Eytan M. Stein, MD
Physicians: maximum of 2.0 AMA PRA Category 1 Credits Released: July 10, 2019 Expiration: July 9, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Agios Pharmaceuticals
Boston Biomedical
Celgene Corporation
Daiichi Sankyo

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?